AU2016202490A1 - 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment - Google Patents

1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment

Info

Publication number: AU2016202490A1
Authority: AU; Australia
Prior art keywords: dimethylphenylsulfanyl; piperazine; phenyl; compound; treatment
Prior art date: 2006-06-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2016202490A

Inventor

Benny Bang-Andersen

Jorgen Brodersen

Andre Faldt

Rene Holm

Morten Jorgensen

Heidi Lopez De Diego

Michael J. Mealy

Nicholas Moore

Arne Mork

Lone Munch Ringgaard

Michael Harold Rock

Tine Bryan Stensbol

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

H Lundbeck AS

Original Assignee

H Lundbeck AS

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-06-16

Filing date

2016-04-20

Publication date

2016-05-12

2016-04-20 Application filed by H Lundbeck AS filed Critical H Lundbeck AS

2016-05-12 Publication of AU2016202490A1 publication Critical patent/AU2016202490A1/en

2017-10-24 Priority to AU2017251723A priority Critical patent/AU2017251723A1/en

Status Abandoned legal-status Critical Current

Links

102100022738 5-hydroxytryptamine receptor 1A Human genes 0.000 title 1
101710138638 5-hydroxytryptamine receptor 1A Proteins 0.000 title 1
208000028698 Cognitive impairment Diseases 0.000 title 1
208000010877 cognitive disease Diseases 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1
230000000694 effects Effects 0.000 title 1
230000000697 serotonin reuptake Effects 0.000 title 1
YQNWZWMKLDQSAC-UHFFFAOYSA-N vortioxetine Chemical compound CC1=CC(C)=CC=C1SC1=CC=CC=C1N1CCNCC1 YQNWZWMKLDQSAC-UHFFFAOYSA-N 0.000 title 1

AU2016202490A 2006-06-16 2016-04-20 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment Abandoned AU2016202490A1 (en)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
AU2017251723A AU2017251723A1 (en)	2006-06-16	2017-10-24	1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
DKPA200600824		2006-06-16
US60/805,014		2006-06-16
US60/826,666		2006-09-22
DKPA200601223		2006-09-22
DKPA200601384		2006-10-25
US60/862,826		2006-10-25
DKPA200700427		2007-03-20

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2013254939A Division AU2013254939A1 (en)	2006-06-16	2013-11-08	1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2017251723A Division AU2017251723A1 (en)	2006-06-16	2017-10-24	1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment

Publications (1)

Publication Number	Publication Date
AU2016202490A1 true AU2016202490A1 (en)	2016-05-12

Family

ID=

Similar Documents

Publication	Publication Date	Title
ZA200810017B (en)	2010-04-28	1- [2- (2, 4-Dimethylphenylsulfanyl) -phenyl] piperazine as a compound with combined serotonin Reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment
UA97392C2 (en)	2012-02-10	1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of pain
IL205466A0 (en)	2010-12-30	Therapeutic uses of compounds having combined sert, 5 - ht3 and 5 - ht1a activity
WO2009048101A1 (en)	2009-04-16	Amide compound
EP2368871B8 (en)	2017-10-11	Process for the preparation of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol
PL2182949T3 (en)	2013-06-28	(2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of use thereof
IL200705A0 (en)	2010-05-17	New micro-organisms for the production of 1,2-propanediol obtained by a combination of evolution and rational design
ZA200806066B (en)	2009-05-27	Process for the preparation of 6,6-dimethyl-3-azabicyclo[3.1.0]-hexane compounds and enantiomeric salts thereof
HRP20130819T1 (en)	2013-09-30	New compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine
SI2114405T1 (en)	2015-06-30	methylparaben cocrystal form "A" of (4-(3-Fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-l-yl)-(5-methanesulfonyl-2- ((S) -2,2,2-trifluoro- 1 -methyl-ethoxy) -phenyl) -methanone
ZA201000394B (en)	2012-06-27	Process and intermediates for the synthesis of 1,2-substituted 3,4-dioxo-1-cyclobutene compounds
IL199239A0 (en)	2010-03-28	Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy)-3-bromo-6-
AU2016202490A1 (en)	2016-05-12	1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment
AU2008306604A8 (en)	2010-05-13	Process for the preparation of zolmitriptan, salts and solvates thereof
TNSN08461A1 (en)	2010-04-14	Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain.
IL206674A0 (en)	2010-12-30	N-[3-bromo-2-chloro-4-(4,5-dihydro-1h-imidazol-2-ylmethyl)-phenyl]-methanesulfonamide as alpha-1 a adrenergic partial agonist for the treatment of incontinence
USD614900S1 (en)	2010-05-04	Blanket
GB2433504B (en)	2010-04-28	Cyclopentane carboxylate compounds, process and intermediates for preparing the same and use thereof
HK1143132A (en)	2010-12-24	Process and intermediates for the synthesis of 1,2-substituted 3,4-dioxo-1-cyclobutene compounds
HK1130783A (en)	2010-01-08	Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia
IL206613A0 (en)	2010-12-30	Process for the production of 4-(substituted phenyl) hexahydropyrido[2,1-c][1,4]oxazin-6-one
HK1118054A (en)	2009-01-30	New oxabispidine compounds for the treatment of cardiac arrhytmias
IL187417A0 (en)	2008-02-09	New oxabispidine compounds for the treatment of cardiac arrhythmias